Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma
Journal
Therapeutic advances in medical oncology
Journal Volume
14
Date Issued
2022
Abstract
A definitive diagnosis of pulmonary sarcomatoid carcinoma cannot be made with small biopsies. In clinical practice, a diagnosis of advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma (NSCLCsg), or possible sarcomatoid carcinoma, is acceptable. Therefore, we aimed to investigate the treatment patterns and outcomes of advanced NSCLCsg.
Subjects
immune checkpoint inhibitor; non-small-cell lung cancer with spindle cell and/or giant cell carcinoma; overall survival; programmed death ligand-1; pulmonary sarcomatoid carcinoma
SDGs
Publisher
SAGE PUBLICATIONS LTD
Type
journal article